ESC 24: FINE-HEART: Finerenone in HF & CKD

ESC 24: FINE-HEART: Finerenone in HF & CKDПодробнее

ESC 24: FINE-HEART: Finerenone in HF & CKD

Heart failure in patients with CKD: diagnosis and therapeutic approachesПодробнее

Heart failure in patients with CKD: diagnosis and therapeutic approaches

HFA 24: FINE-HEART: Design & Baseline CharacteristicsПодробнее

HFA 24: FINE-HEART: Design & Baseline Characteristics

ESC 24: MRAs in Heart FailureПодробнее

ESC 24: MRAs in Heart Failure

ESC 2022: FIDELITY: Finerenone in Pts With Chronic Kidney Disease | Prof Gerasimos FilippatosПодробнее

ESC 2022: FIDELITY: Finerenone in Pts With Chronic Kidney Disease | Prof Gerasimos Filippatos

ESC TV at #ESCCongress 2021 - FIGARO-DKDПодробнее

ESC TV at #ESCCongress 2021 - FIGARO-DKD

HFSA 24: Finerenone Across the Ejection Fraction Spectrum: FINEARTS-HFПодробнее

HFSA 24: Finerenone Across the Ejection Fraction Spectrum: FINEARTS-HF

George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney DiseaseПодробнее

George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

Optimization of heart failure therapy: what's new from ESC Congress 2024?Подробнее

Optimization of heart failure therapy: what's new from ESC Congress 2024?

2023 ESC Guidelines Update: Acute & Chronic Heart FailureПодробнее

2023 ESC Guidelines Update: Acute & Chronic Heart Failure

ESC TV at Heart Failure 2018 - Cardiac contractility modulationПодробнее

ESC TV at Heart Failure 2018 - Cardiac contractility modulation

ESC Guidelines: Heart failureПодробнее

ESC Guidelines: Heart failure

ESC TV at Heart Failure 2018 - Primary results from REPORT-HПодробнее

ESC TV at Heart Failure 2018 - Primary results from REPORT-H

Finerenone, a non-steroidal MRAПодробнее

Finerenone, a non-steroidal MRA

ESC TV 2014 - HEART FAILUREПодробнее

ESC TV 2014 - HEART FAILURE

ESC TV at #ESCCongress 2021 - FIDELITY AnalysisПодробнее

ESC TV at #ESCCongress 2021 - FIDELITY Analysis